FOXP3 Genetic Variation at Position -2383 C/T (rs3761549) in Patients with Breast Cancer

被引:0
|
作者
Shiri, Zahra [1 ]
Mansouri, Reza [1 ,2 ]
Haghshenas, Mohammad Reza [3 ]
Talei, Abdolrasoul [4 ,5 ]
Erfani, Nasrollah [3 ,6 ]
机构
[1] Shahid Sadoughi Univ Med Sci, Int Branch, Fac Med, Dept Immunol, Yazd, Iran
[2] Shahid Sadoughi Univ Med Sci, Hematol & Oncol Res Ctr, Yazd, Iran
[3] Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Shiraz, Iran
[4] Shiraz Univ Med Sci, Breast Dis Res Ctr, Shiraz, Iran
[5] Shiraz Univ Med Sci, Sch Med, Dept Surg, Shiraz, Iran
[6] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz, Iran
关键词
Breast cancer; FOXP3; gene; Single nucleotide polymorphism; PCR-RFLP; RISK-FACTORS; T-CELLS; POLYMORPHISMS; EPIDEMIOLOGY; WOMEN; IPEX;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We investigated the possibility of an association between the C-2383T polymorphism (rs3761549) in the promoter region of the FOXP3 gene with breast cancer. Methods: The study groups consisted of 250 women diagnosed with breast cancer (case group) and 250 healthy women (control group). Polymerase chain reaction-restriction fragment length polymorphism was performed for genotyping. Results: Breast cancer cases had a C allele frequency of 455 (91%) and T allele frequency of 45 (9%). The control group had a C allele frequency of 468 (93.6%) and 32 (6.4%) for the T allele. The CC genotype was present in 206 (82.4%) patients, 43 (17.2%) patients had the CT genotype, and the TT genotype was observed in 1 (0.4%) patient. In the control group, 219 (87.6%) had the CC genotype, whereas 30 (12%) had the CT genotype, and 1 (0.4%) had the TT genotype. Statistical analysis revealed no significant differences in the distribution of alleles and genotypes between patients and controls (P>0.05). There was no significant association between genotype distribution and patients' clinicopathological factors. Conclusion: Our results do not support an association between the FOXP3 -2383 C/T polymorphism and breast cancer in a population from southern Iran.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 50 条
  • [1] Genetic association study of promoter variation rs3761549 in the FOXP3 gene of Iranian patients diagnosed with brain tumour
    Moradi, Mehdi
    Naeimi, Sirous
    Asadzade, Shekofeh
    Rahi, Azar
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (07) : 11915 - 11920
  • [2] Role of FOXP3 gene polymorphisms (SNPs rs3761547, rs3761549, and rs2232365) in the development of Type 2 diabetes mellitus
    Chua, Lee Suan
    Dawood, Dawood Ali Salim
    Swee, Tan Tian
    Fadhil, Alshemary Ahmed
    GENE REPORTS, 2021, 24
  • [3] FOXP3 rs3761549 polymorphism predicts long-term renal allograft function in patients receiving cyclosporine-based immunosuppressive regimen
    Xu, Qin-xia
    Qiu, Xiao-yan
    Jiao, Zheng
    Zhang, Ming
    Zhong, Ming-kang
    GENE, 2018, 644 : 93 - 100
  • [4] Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study
    D'Amico, Fabio
    Skarmoutsou, Evangelia
    Trovato, Chiara
    Marchini, Maurizio
    Malaponte, Grazia
    Caronni, Monia
    Scorza, Raffaella
    Spandidos, Demetrios A.
    Mazzarino, Maria Clorinda
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S116 - S116
  • [5] Investigation of FOXP3 genetic variations at positions-2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma
    Haghighi, Maryam Fazelzadeh
    Al Ghayumi, Mohammad
    Behzadnia, Farzane
    Erfani, Nasrollah
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 18 (05) : 465 - 471
  • [6] Clinical significance of breast ultrasound and FOXP3 in breast cancer patients
    Lin, Shibin
    Wan, Ying
    Huang, Li
    Chen, Kailiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (05): : 4943 - 4948
  • [7] Evaluation of foxp3 expression in sentinel nodes in breast cancer patients.
    Matsuura, K
    Yamaguchi, Y
    Osaki, A
    Ueno, H
    Ohara, M
    Arihiro, K
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S199 - S199
  • [8] FOXP3 Expression in Tumor Cells Associated with the Prognosis in Breast Cancer Patients
    Takenaka, M.
    Toh, U.
    Seki, N.
    Kawahara, A.
    Hattori, S.
    Iwakuma, N.
    Yamaguchi, R.
    Yano, H.
    Shirouzu, K.
    Kage, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S140 - S140
  • [9] Foxp3 promoter polymorphism (rs3761548) in breast cancer progression: a study from India
    Jahan, Parveen
    Ramachander, V. R. Vinish
    Maruthi, G.
    Nalini, S.
    Latha, K. Prasanna
    Murthy, T. S. R.
    TUMOR BIOLOGY, 2014, 35 (04) : 3785 - 3791
  • [10] FOXP3 Positive Regulatory T Lymphocytes and Epithelial FOXP3 Expression in Synchronous Normal, Ductal Carcinoma In Situ and Invasive Cancer of the Breast.
    Lal, A.
    Chan, L.
    DeVries, S.
    Chin, K.
    Benz, C. C.
    Chen, Y-Y
    Hwang, S.
    Waldman, F. M.
    CANCER RESEARCH, 2011, 71